In BCC, the hedgehog signaling pathway is typically activated by mutations that lead to PTCH1 gene dysfunction, which is almost universally observed in patients with BCC nevus syndrome and in most patients (80%–90%) with sporadic BCC tumors, whereas 10% of patients have SMO gene mutations [14, 18]. This evidence concerns the gene PTCH1 and skin basal cell carcinoma.